Diebold Nixdorf Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $3.9B+3.2% YoYTTM through 30 Jun 2026
Net Income $111.2MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 23.9% |
| EBITDA Margin | 9.6% |
| Operating Margin | 3.7% |
| Net Margin | 2.9% |
Returns
10.8%ROE
2.9%ROA
7.2%ROIC
Balance Sheet Health
Debt / Equity0.92x
Current Ratio1.28x
Net Debt$580.8M
Cash & Equivalents$358.6M
Quality Metrics
Altman Z-Score1.89
Piotroski F-Score7 / 9
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $3.8B
Diluted EPS$3.02TTMFY2025: $2.54
Dividend
No dividend
Capital Allocation
R&D Spend$84.2M
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.